Stockreport

DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report
PDF Received Regulatory Approval from Health Canada Supporting Initiation of Phase 2 DM199 Study in Early-onset Preeclampsia.DM199 Preeclampsia Phase 2 Investigator-Sponsore [Read more]